{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:51:56Z","timestamp":1791856316847,"version":"4.3.4"},"reference-count":260,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2002,10,3]],"date-time":"2002-10-03T00:00:00Z","timestamp":1033603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present paper is a review of the treatment of anxious disorders by the current pharmaceutical medications; a short epidemiological survey is given for anxious disorders including: general anxiety disorder, panic disorder, obsessive compulsive disorder, social anxiety and post\u2010traumatic stress disorder. For all these disorders there are proposals of treatment built on literature data mainly on meta\u2010analysis as well on personal experience. Copyright \u00a9 2002 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hup.435","type":"journal-article","created":{"date-parts":[[2002,12,2]],"date-time":"2002-12-02T13:47:08Z","timestamp":1038836828000},"page":"383-400","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacotherapy of anxious disorders"],"prefix":"10.1002","volume":"17","author":[{"given":"Michel","family":"Bourin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00012"},{"key":"e_1_2_1_3_1","first-page":"165","article-title":"Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder","volume":"34","author":"Allgulander C","year":"1998","journal-title":"Psychopharmacol Bull"},{"issue":"5","key":"e_1_2_1_4_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder","volume":"155","author":"American Psychiatric Association","year":"1998","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700035315"},{"key":"e_1_2_1_6_1","first-page":"135","article-title":"A double\u2010blind placebo\u2010controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia","volume":"32","author":"Bakish D","year":"1996","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"e_1_2_1_7_1","first-page":"S77","article-title":"Reversible monoamine oxidase\u2014a inhibitors in panic disorder","volume":"16","author":"Bakish D","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200007001-00005"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.2.120"},{"issue":"3","key":"e_1_2_1_10_1","first-page":"26","article-title":"Medication discontinuation in panic disorder","volume":"53","author":"Ballenger JC","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00220-6"},{"issue":"8","key":"e_1_2_1_12_1","first-page":"47","article-title":"Consensus statement on panic disorder from the international consensus group on depression and anxiety","volume":"59","author":"Ballenger JC","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.36"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(95)90248-1"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199707000-00013"},{"issue":"17","key":"e_1_2_1_16_1","first-page":"60","article-title":"Topiramate in post\u2010traumatic stress disorder","volume":"62","author":"Berlant JL","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0104"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(97)89646-0"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199606003-00005"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130046008"},{"key":"e_1_2_1_21_1","first-page":"180","volume-title":"Psychiatric Disorders in America: The Epidemiologic Catchment Area Study","author":"Blazer DG","year":"1991"},{"key":"e_1_2_1_22_1","first-page":"259","article-title":"Drug mechanisms in anxiety","volume":"2","author":"Bourin M","year":"2001","journal-title":"Curr Op Invest Drug"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199503000-00006"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.14.1837"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.7.973"},{"issue":"17","key":"e_1_2_1_26_1","first-page":"55","article-title":"Outcomes of post\u2010traumatic stress disorder","volume":"62","author":"Breslau N","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"17","key":"e_1_2_1_27_1","first-page":"16","article-title":"The epidemiology of post\u2010traumatic stress disorder: what is the extent of the problem?","volume":"62","author":"Breslau N","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810270028003"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054884"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(90)90427-4"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.1020"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820160064008"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199210002-00007"},{"key":"e_1_2_1_34_1","first-page":"279","article-title":"Results of a double\u2010blind placebo\u2010controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive\u2010compulsive disorder","volume":"26","author":"Chouinard G","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb31526.x"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810320054008"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.1.17"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(2000)11:1<27::AID-DA4>3.0.CO;2-O"},{"issue":"29","key":"e_1_2_1_39_1","first-page":"57A","article-title":"Benzodiazepine sensitivity in anxiety disorders (Abstract)","volume":"29","author":"Cowleys DS","year":"1991","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.160.2.191"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(93)90023-U"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90603-W"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jts.2490100114"},{"issue":"8","key":"e_1_2_1_44_1","first-page":"17","article-title":"Long\u2010term treatment of panic disorder","volume":"59","author":"Davidson JRT","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"18","key":"e_1_2_1_45_1","first-page":"33","article-title":"Management of post\u2010traumatic syndrome disorder diagnosis and therapeutic issues","volume":"60","author":"Davidson JRT","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0805"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950120047008"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810150059010"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.7.1024"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199711000-00001"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1974"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00008"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.485"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.2.252"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199802000-00020"},{"key":"e_1_2_1_56_1","first-page":"245","article-title":"An open label trial of nefazodone in high comorbidity panic disorder","volume":"57","author":"De Martinis NA","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119100500414"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245749"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199619020-00002"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401239409148837"},{"key":"e_1_2_1_61_1","first-page":"53","volume-title":"Psychiatric Disorder in America: The Epidemiologic Catchment Area Study","author":"Eaton W","year":"1991"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03926.x"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/jts.2490100210"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00011"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000118565"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb01376.x"},{"key":"e_1_2_1_67_1","first-page":"361","article-title":"Valproate in combat\u2010related post\u2010traumatic stress disorder","volume":"52","author":"Fesler FA","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_68_1","first-page":"66","article-title":"Buspirone in combat\u2010related post\u2010traumatic stress disorder","volume":"57","author":"Fichtner CG","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"e_1_2_1_69_1","first-page":"18","article-title":"Pharmacologic treatment of obsessive\u2010compulsive disorder: comparative studies","volume":"58","author":"Flament MF","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_70_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/070674370104600408","article-title":"Olanzapine augmentation of serotonin reuptake inhibitors in obsessive\u2010compulsive disorder: an open study","volume":"46","author":"Francobanderia G","year":"2001","journal-title":"Can J Psychiatry"},{"key":"e_1_2_1_71_1","first-page":"301","article-title":"Fluvoxamine versus clomipramine in the treatment of obsessive\u2010compulsive disorder: a multicenter, randomized, double\u2010blind, parallel group comparison","volume":"55","author":"Freeman CPL","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_72_1","first-page":"270","article-title":"Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study","volume":"8","author":"Fyer AJ","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-7154(1996)2:4<173::AID-ANXI3>3.0.CO;2-P"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1159\/000118837"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.23.3082"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(95)71629-2"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810340070009"},{"issue":"18","key":"e_1_2_1_78_1","first-page":"27","article-title":"Obsessive compulsive disorder diagnosis and treatment","volume":"60","author":"Goodman WK","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199603000-00003"},{"issue":"6","key":"e_1_2_1_80_1","first-page":"16","article-title":"Biological approaches to treatment resistant obsessive\u2010compulsive disorder","volume":"54","author":"Goodman WK","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_81_1","first-page":"36","article-title":"Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive\u2010compulsive disorder?","volume":"51","author":"Goodman WK","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198710000-00007"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.5.819"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950160039008"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950130053006"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199506000-00001"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-4993(18)30257-8"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401230109148960"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145701002681"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0904"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199608000-00004"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110001400110"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70336-9"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199310000-00004"},{"key":"e_1_2_1_95_1","first-page":"293","article-title":"Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms","volume":"49","author":"Hoehn\u2010Saric R","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780290074008"},{"issue":"8","key":"e_1_2_1_97_1","first-page":"3","article-title":"Obsessive\u2010compulsive and spectrum disorders: overview and quality of life issues","volume":"57","author":"Hollander E","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_98_1","first-page":"41","article-title":"Neuroimaging and neurobiology of obsessive\u2010compulsive disorder","volume":"22","author":"Huguelet P","year":"1996","journal-title":"Encephale"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90625-4"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199004000-00008"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.9.1261"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1993.tb01740.x"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048679109062643"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1998.tb05960.x"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09911.x"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800360042006"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(01)00100-6"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50003.x"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.9.1368"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.613"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950240066012"},{"key":"e_1_2_1_112_1","first-page":"107","article-title":"Sertraline efficacy in depressed combat veterans with post\u2010traumatic stress disorder","volume":"13","author":"Kline NA","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199604000-00004"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.88"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.6.783"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199106000-00011"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(87)90017-5"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199904000-00013"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.3.373"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199204000-00010"},{"issue":"17","key":"e_1_2_1_121_1","first-page":"33","article-title":"Comorbidity in social anxiety disorder: impact on disease burden and management","volume":"59","author":"Lecrubier Y","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"e_1_2_1_122_1","first-page":"11","article-title":"Impact of comorbidity on the treatment of panic disorder","volume":"59","author":"Lecrubier Y","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb00388.x"},{"key":"e_1_2_1_124_1","first-page":"25","article-title":"Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial","volume":"25","author":"Leinonen E","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820180023003"},{"issue":"14","key":"e_1_2_1_126_1","first-page":"39","article-title":"New developments in the treatment of obsessive\u2010compulsive disorder","volume":"58","author":"Leonard HL","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n1006"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1159\/000414022"},{"key":"e_1_2_1_129_1","first-page":"159","article-title":"Phenelzine vs atenolol in social phobia: a placebo\u2010controlled comparison","volume":"53","author":"Liebowitz MR","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0113"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.159.4.531"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(86)72590-5"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(95)00071-V"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00003"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-7154(1996)2:2<61::AID-ANXI1>3.0.CO;2-G"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830020077009"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.9.1359"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1103"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110026004"},{"issue":"2","key":"e_1_2_1_140_1","first-page":"39","article-title":"Comorbidity and its effect on panic disorder","volume":"60","author":"Marshall JR","year":"1996","journal-title":"Bull Menninger Clin"},{"key":"e_1_2_1_141_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1982"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199802000-00003"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0305"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198604000-00008"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.8.794"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.4.647"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950040046006"},{"key":"e_1_2_1_148_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.5.652"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199106000-00005"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)90024-8"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.2307\/2136565"},{"key":"e_1_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.11.1570"},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199208000-00007"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00011"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200103000-00002"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(93)90266-O"},{"key":"e_1_2_1_157_1","unstructured":"M\u00fcllerN.2000.Fr\u00fchstadien der Sozialen Phobie: Risiken Erscheinungsformen und Konsequenzen. Dissertation. University of Bamberg."},{"key":"e_1_2_1_158_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199304000-00004"},{"key":"e_1_2_1_159_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-7154(1996)2:4<192::AID-ANXI6>3.0.CO;2-Q"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1997.tb126684.x"},{"key":"e_1_2_1_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70205-7"},{"key":"e_1_2_1_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30713-5"},{"key":"e_1_2_1_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00002"},{"issue":"17","key":"e_1_2_1_164_1","first-page":"4","article-title":"Brain mechanisms of social anxiety disorder","volume":"59","author":"Nutt DJ","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.167.3.374"},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.1068"},{"key":"e_1_2_1_167_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1989"},{"key":"e_1_2_1_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(93)90025-W"},{"key":"e_1_2_1_169_1","first-page":"193","article-title":"Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study","volume":"20","author":"Pecknold JC","year":"1995","journal-title":"J Psychiatr Neuorosci"},{"key":"e_1_2_1_170_1","first-page":"147","article-title":"Dependence on benzodiazepine: clinical and biological aspects","volume":"20","author":"Pelissolo A","year":"1994","journal-title":"Encephale"},{"key":"e_1_2_1_171_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220042005"},{"key":"e_1_2_1_172_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202000-00003"},{"key":"e_1_2_1_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199108000-00004"},{"key":"e_1_2_1_174_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.9.1189"},{"issue":"9","key":"e_1_2_1_175_1","first-page":"20","article-title":"Social anxiety disorder: designing a pharmacologic treatment strategy","volume":"60","author":"Pollack MH","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_176_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.11.1010"},{"key":"e_1_2_1_177_1","first-page":"667","article-title":"Venlafaxine for panic disorder: result from a double blind, placebo\u2010controlled study","volume":"32","author":"Pollack MH","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_178_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0508"},{"key":"e_1_2_1_179_1","first-page":"1283","article-title":"Lithium and tryptophan augmentation in clomipramine resistant obsessive\u2010compulsive disorder","volume":"141","author":"Rasmussen SA","year":"1987","journal-title":"Am J Psychiatry"},{"issue":"10","key":"e_1_2_1_180_1","first-page":"5","article-title":"Epidemiology and differential diagnosis of obsessive\u2010compulsive disorder","volume":"55","author":"Rasmussen SA","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"13","key":"e_1_2_1_181_1","first-page":"9","article-title":"Treatment strategies for chronic and refractory obsessive\u2010compulsive disorder","volume":"58","author":"Rasmussen SA","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830050014003"},{"key":"e_1_2_1_183_1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1037\/0022-006X.61.6.984","article-title":"Prevalence of civilian trauma and post\u2010traumatic stress disorder in a representational national sample of women","volume":"61","author":"Resnick HS","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"e_1_2_1_184_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340060045024"},{"key":"e_1_2_1_185_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820230054005"},{"key":"e_1_2_1_186_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.968"},{"key":"e_1_2_1_187_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130067010"},{"key":"e_1_2_1_188_1","first-page":"206","article-title":"Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat\u2010induced post\u2010traumatic stress disorder","volume":"51","author":"Risse SC","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_189_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb03190.x"},{"key":"e_1_2_1_190_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09660.x"},{"key":"e_1_2_1_191_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)10:1<1::AID-DA1>3.0.CO;2-9"},{"key":"e_1_2_1_192_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199710000-00008"},{"key":"e_1_2_1_193_1","doi-asserted-by":"publisher","DOI":"10.3109\/10673229309017052"},{"key":"e_1_2_1_194_1","first-page":"61","volume-title":"The Vietnam Veteran Redefined","author":"Roth LM","year":"1986"},{"key":"e_1_2_1_195_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979311"},{"issue":"12","key":"e_1_2_1_196_1","first-page":"7","article-title":"Epidemiology of obsessive\u2010compulsive disorder: a world view","volume":"58","author":"Sasson Y","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00082-2"},{"key":"e_1_2_1_198_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200101000-00016"},{"key":"e_1_2_1_199_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199502000-00014"},{"key":"e_1_2_1_200_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.172.1.70"},{"key":"e_1_2_1_201_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpsyc.1992.01820040034004","article-title":"Social phobia: comorbidity and morbidity in an epidemiologic sample","volume":"49","author":"Schneier FR","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_1_202_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.8.1210"},{"key":"e_1_2_1_203_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130053009"},{"key":"e_1_2_1_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90158-3"},{"key":"e_1_2_1_205_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305133281907"},{"key":"e_1_2_1_206_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.630"},{"issue":"18","key":"e_1_2_1_207_1","first-page":"16","article-title":"Current concepts in treatment","volume":"60","author":"Sheehan DV","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_208_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140053006"},{"key":"e_1_2_1_209_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015060-00004"},{"key":"e_1_2_1_210_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199804000-00005"},{"key":"e_1_2_1_211_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300408"},{"key":"e_1_2_1_212_1","first-page":"63","article-title":"Fluvoxamine vs clomipramine treatment in obsessive\u2010compulsive disorder: a preliminary study","volume":"8","author":"Smeraldi E","year":"1992","journal-title":"New Trends Exp Clin Psychiatry"},{"key":"e_1_2_1_213_1","first-page":"5","article-title":"Trauma: prevalence, impairment, service use, and cost","volume":"58","author":"Solomon SD","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_214_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830200083012"},{"key":"e_1_2_1_215_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<131::AID-DA5>3.0.CO;2-H"},{"issue":"11","key":"e_1_2_1_216_1","first-page":"29","article-title":"Comorbidity in generalized anxiety disorder: impact and implication","volume":"62","author":"Stein DJ","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_217_1","first-page":"402","article-title":"A double\u2010blind placebo\u2010controlled trial of paroxetine in management of social phobia (social anxiety disorder) in South Africa","volume":"89","author":"Stein DJ","year":"1999","journal-title":"SA Med J"},{"key":"e_1_2_1_218_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200008002-00006"},{"key":"e_1_2_1_219_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199503000-00002"},{"key":"e_1_2_1_220_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606000-00005"},{"issue":"1","key":"e_1_2_1_221_1","first-page":"511","article-title":"Subtypes of social phobia and comorbidity depression and other anxiety disorders","volume":"50","author":"Stein MB","year":"1998","journal-title":"J Affect Disord"},{"key":"e_1_2_1_222_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.8.1120"},{"key":"e_1_2_1_223_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291797005242"},{"key":"e_1_2_1_224_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.8.708"},{"key":"e_1_2_1_225_1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1037\/0021-843X.104.3.526","article-title":"Social phobia: an analysis of possible developmental factors","volume":"104","author":"Stemberger RT","year":"1995","journal-title":"J Abnorm Psychol"},{"key":"e_1_2_1_226_1","doi-asserted-by":"publisher","DOI":"10.1002\/anxi.3070010505"},{"key":"e_1_2_1_227_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0307c"},{"key":"e_1_2_1_228_1","first-page":"69","article-title":"Double\u2010blind, placebo\u2010controlled comparison of clonazepam and alprazolam for panic disorder","volume":"52","author":"Tesar GE","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_229_1","first-page":"141","article-title":"Dopamine reuptake site density in patient with social phobia","volume":"22","author":"Tiihonen J","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"e_1_2_1_230_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950070051010"},{"key":"e_1_2_1_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-547625-6.50035-0"},{"key":"e_1_2_1_232_1","doi-asserted-by":"publisher","DOI":"10.1053\/comp.2002.32355"},{"key":"e_1_2_1_233_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1105"},{"key":"e_1_2_1_234_1","first-page":"517","article-title":"Fluoxetine in post\u2010traumatic stress disorder","volume":"55","author":"Van der Kolk BA","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_235_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200008002-00004"},{"key":"e_1_2_1_236_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244762"},{"key":"e_1_2_1_237_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199608000-00005"},{"key":"e_1_2_1_238_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.3.353"},{"key":"e_1_2_1_239_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.6.549"},{"key":"e_1_2_1_240_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262040-00010"},{"key":"e_1_2_1_241_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216060-00006"},{"issue":"2","key":"e_1_2_1_242_1","first-page":"6","article-title":"Panic disorder: impact on quality of life","volume":"52","author":"Weissman NM","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_243_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830160021003"},{"issue":"3","key":"e_1_2_1_244_1","first-page":"5","article-title":"The cross\u2010national epidemiology of obsessive\u2010compulsive disorder","volume":"55","author":"Weissman MM","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90447-X"},{"issue":"17","key":"e_1_2_1_246_1","first-page":"20","article-title":"The nature of social anxiety disorder","volume":"59","author":"Westemberg HMG","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_247_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200007001-00003"},{"issue":"11","key":"e_1_2_1_248_1","first-page":"15","article-title":"Generalized anxiety disorder: nature and course","volume":"62","author":"Wittchen HU","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_249_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798008174"},{"key":"e_1_2_1_250_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950050015002"},{"key":"e_1_2_1_251_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(91)90044-Y"},{"key":"e_1_2_1_252_1","first-page":"134","article-title":"Panic disorder: treatment with valproate","volume":"55","author":"Woodman CL","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"17","key":"e_1_2_1_253_1","first-page":"41","article-title":"Biology of post\u2010traumatic stress disorder","volume":"62","author":"Yehuda R","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_254_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.12.1705"},{"key":"e_1_2_1_255_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.168.3.308"},{"key":"e_1_2_1_256_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.596"},{"key":"e_1_2_1_257_1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1176\/ajp.156.5.804a","article-title":"Post\u2010traumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans","volume":"156","author":"Zatrick DF","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_258_1","first-page":"439","article-title":"Efficacy of fluoxetine in Austrian patients with obsessive\u2010compulsive disorder","volume":"111","author":"Zitterl W","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_1_259_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00013"},{"key":"e_1_2_1_260_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.468"},{"key":"e_1_2_1_261_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2000.tb10947.x"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.435","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:12:10Z","timestamp":1700395930000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,3]]},"references-count":260,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1002\/hup.435"],"URL":"https:\/\/doi.org\/10.1002\/hup.435","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,3]]}}}